Literature DB >> 14904395

The virulence-enhancing factor of mucins. IV. The role of particulate insoluble matter and a viscous medium in virulence enhancement, with a revised assay of the third factor involved.

H SMITH, P W HARRIS-SMITH, J L STANLEY, S PETO.   

Abstract

Keywords:  BACTERIA/virulence; GASTRIC MUCIN

Mesh:

Substances:

Year:  1951        PMID: 14904395      PMCID: PMC1197633          DOI: 10.1042/bj0500211

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


× No keyword cloud information.
  5 in total

1.  MUCIN AS A RESISTANCE-LOWERING SUBSTANCE.

Authors:  L Olitzki
Journal:  Bacteriol Rev       Date:  1948-06

2.  The virulence-enhancing factor of mucins. 1. A biological assay of virulence-enhancing activity.

Authors:  H Smith
Journal:  Biochem J       Date:  1950-03       Impact factor: 3.857

3.  The virulence-enhancing factor of mucins. 2. Fractionation studies on hog gastric mucin.

Authors:  H Smith
Journal:  Biochem J       Date:  1950-03       Impact factor: 3.857

4.  Studies in immunochemistry: 7. The isolation from hog gastric mucin of the polysaccharide-amino acid complex possessing blood group A specificity.

Authors:  W T Morgan; H K King
Journal:  Biochem J       Date:  1943       Impact factor: 3.857

5.  The virulence-enhancing factor of mucins. 3. further fractionation of hog gastric mucin; an additional factor in the adjuvant action.

Authors:  H SMITH
Journal:  Biochem J       Date:  1951-04       Impact factor: 3.857

  5 in total
  8 in total

1.  Differential effect of hog gastric mucin on properdin and host resistance to infection.

Authors:  C W DEWITT
Journal:  J Bacteriol       Date:  1958-12       Impact factor: 3.490

2.  The virulence-enhancing factor of mucins. 7. The remaining components of the third factor involved in virulence enhancement.

Authors:  H SMITH; H T ZWARTOUW; R C GALLOP; P W HARRIS-SMITH
Journal:  Biochem J       Date:  1953-03       Impact factor: 3.857

3.  The virulence-enhancing factor of mucins. VI. Identification of a heparin as the main component of the third factor involved in virulence enhancement.

Authors:  H SMITH; R C GALLOP; P W HARRIS-SMITH; J L STANLEY
Journal:  Biochem J       Date:  1952-09       Impact factor: 3.857

4.  The virulence-enhancing factor of mucins. V. The different components of the third factor involved in virulence enhancement.

Authors:  H SMITH; R C GALLOP; J L STANLEY
Journal:  Biochem J       Date:  1952-09       Impact factor: 3.857

5.  Comparative studies on Salmonella typhi grown in vivo and in vitro: 1. Virulence, toxicity, production of infection-promoting substances and DPN-ase activity.

Authors:  A L Olitzki; D Godinger
Journal:  J Hyg (Lond)       Date:  1963-03

6.  The action of mucin in promoting infections: the anticomplementary effect of mucin extracts and certain other substances.

Authors:  H P LAMBERT; J RICHLEY
Journal:  Br J Exp Pathol       Date:  1952-08

7.  Lethal Haemophilus influenzae type b infection in mice.

Authors:  M I Marks; E J Ziegler; H Douglas; L B Corbeil
Journal:  Infection       Date:  1982 Sep-Oct       Impact factor: 3.553

8.  Mouse virulence of K(L) antigen-containing strains of Escherichia coli.

Authors:  G Wolberg; C W DeWitt
Journal:  J Bacteriol       Date:  1969-11       Impact factor: 3.490

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.